Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy.

PubWeight™: 4.13‹?› | Rank: Top 1%

🔗 View Article (PMID 3014348)

Published in Nature on August 15, 1986

Authors

L M Kunkel, J F Hejtmancik, C T Caskey, A Speer, A P Monaco, W Middlesworth, C A Colletti, C Bertelson, U Müller, M Bresnan, F Shapiro, U Tantravahi, J Speer, S A Latt, R Bartlett, M A Pericak-Vance, A D Roses, M W Thompson, P N Ray, R G Worton, K H Fischbeck, P Gallano, M Coulon, C Duros, J Boue, C Junien, J Chelly, G Hamard, M Jeanpierre, M Lambert, J C Kaplan, A Emery, H Dorkins, S McGlade, K E Davies, C Boehm, B Arveiler, C Lemaire, G J Morgan, M J Denton, J Amos, M Bobrow, F Benham, E Boswinkel, C Cole, V Dubowitz, K Hart, S Hodgson, L Johnson, A Walker, L Roncuzzi, A Ferlini, C Nobile, G Romeo, D E Wilcox, N A Affara, M A Ferguson-Smith, M Lindolf, H Kaariainen, A de la Chapelle, V Ionasescu, C Searby, R Ionasescu, E Bakker, G J van Ommen, P L Pearson, C R Greenberg, J L Hamerton, K Wrogemann, R A Doherty, R Polakowska, C Hyser, S Quirk, N Thomas, J F Harper, B T Darras, U Francke

Articles citing this

Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc Natl Acad Sci U S A (2000) 2.83

Genetic mapping of autosomal dominant Charcot-Marie-Tooth disease in a large French-Acadian kindred: identification of new linked markers on chromosome 17. Am J Hum Genet (1990) 2.77

Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. Am J Hum Genet (1989) 2.12

The population genetics of Duchenne: natural and artificial selection in Duchenne muscular dystrophy. J Med Genet (1986) 1.85

Detection of submicroscopic deletions in band 17p13 in patients with the Miller-Dieker syndrome. Am J Hum Genet (1988) 1.83

Identification and regional localization of DNA markers on chromosome 7 for the cloning of the cystic fibrosis gene. Am J Hum Genet (1988) 1.80

Muscular dystrophy in girls with X;autosome translocations. J Med Genet (1986) 1.78

Congenital adrenal hypoplasia, myopathy, and glycerol kinase deficiency: molecular genetic evidence for deletions. Am J Hum Genet (1987) 1.72

A 230kb cosmid walk in the Duchenne muscular dystrophy gene: detection of a conserved sequence and of a possible deletion prone region. Nucleic Acids Res (1987) 1.72

The William Allan memorial award address: X-chromosome inactivation and the location and expression of X-linked genes. Am J Hum Genet (1988) 1.71

DNA probe analysis for carrier detection and prenatal diagnosis of Duchenne muscular dystrophy: a standard diagnostic procedure. J Med Genet (1986) 1.55

Partial gene duplication in Duchenne and Becker muscular dystrophies. J Med Genet (1988) 1.50

The cooperative international neuromuscular research group Duchenne natural history study--a longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods used. Muscle Nerve (2013) 1.48

2004 William Allan Award address. Cloning of the DMD gene. Am J Hum Genet (2005) 1.45

Normal human genomic restriction-fragment patterns and polymorphisms revealed by hybridization with the entire dystrophin cDNA. Am J Hum Genet (1988) 1.41

Deletions of fetal and adult muscle cDNA in Duchenne and Becker muscular dystrophy patients. EMBO J (1987) 1.40

Detection of novel genetic markers by mismatch analysis. Nucleic Acids Res (1989) 1.36

Frequent alterations of visual pigment genes in adrenoleukodystrophy. Am J Hum Genet (1988) 1.32

Partial gene duplication involving exon-Alu interchange results in lipoprotein lipase deficiency. Am J Hum Genet (1990) 1.31

Complementary DNA probes for the Duchenne muscular dystrophy locus demonstrate a previously undetectable deletion in a patient with dystrophic myopathy, glycerol kinase deficiency, and congenital adrenal hypoplasia. J Clin Invest (1989) 1.30

Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy. J Med Genet (1989) 1.30

Gene deletions in X-linked muscular dystrophy. Am J Hum Genet (1989) 1.29

An analysis of exome sequencing for diagnostic testing of the genes associated with muscle disease and spastic paraplegia. Hum Mutat (2012) 1.25

Emerging genetic therapies to treat Duchenne muscular dystrophy. Curr Opin Neurol (2009) 1.20

Restoring dystrophin expression in duchenne muscular dystrophy muscle progress in exon skipping and stop codon read through. Am J Pathol (2011) 1.15

Nonradioactive assay for new microsatellite polymorphisms at the 5' end of the dystrophin gene, and estimation of intragenic recombination. Am J Hum Genet (1991) 1.13

Isolation of a conserved sequence deleted in Duchenne muscular dystrophy patients. Nucleic Acids Res (1987) 1.12

Prenatal identification of a girl with a t(X;4)(p21;q35) translocation: molecular characterisation, paternal origin, and association with muscular dystrophy. J Med Genet (1990) 1.09

DNA studies in a family with Duchenne muscular dystrophy and a deletion at Xp21. Am J Hum Genet (1987) 1.08

Improved diagnosis of Duchenne/Becker muscular dystrophy. J Clin Invest (1990) 1.08

Familial inheritance of a DXS164 deletion mutation from a heterozygous female. Am J Hum Genet (1987) 1.08

Late gadolinium enhanced cardiovascular magnetic resonance in Becker muscular dystrophy. Heart (2004) 1.08

Possibilities and limitation of prenatal diagnosis and carrier determination for Duchenne and Becker muscular dystrophy using cDNA probes. J Med Genet (1989) 1.07

Screening of deletions in the dystrophin gene with the cDNA probes Cf23a, Cf56a, and Cf115. J Med Genet (1990) 1.03

Mild and severe muscular dystrophy associated with deletions in Xp21 of the human X chromosome. J Med Genet (1988) 1.02

Molecular deletion analysis in Duchenne muscular dystrophy. J Med Genet (1986) 1.02

RNA interference inhibits DUX4-induced muscle toxicity in vivo: implications for a targeted FSHD therapy. Mol Ther (2012) 1.00

The use of field-inversion gel electrophoresis for deletion detection in Duchenne muscular dystrophy. Am J Hum Genet (1988) 0.98

Duchenne and Becker muscular dystrophy mutations: analysis using 2.6 kb of muscle cDNA from the 5' end of the gene. Nucleic Acids Res (1987) 0.96

Facioscapulohumeral muscular dystrophy region gene-1 (FRG-1) is an actin-bundling protein associated with muscle-attachment sites. J Cell Sci (2010) 0.96

Prenatal diagnosis of Duchenne muscular dystrophy by DNA analysis. J Med Genet (1986) 0.96

Localisation of Xp21 meiotic exchange points in Duchenne muscular dystrophy families. J Med Genet (1986) 0.95

A new nonsyndromic X-linked sensorineural hearing impairment linked to Xp21.2. Am J Hum Genet (1994) 0.95

Targeted next-generation sequencing as a comprehensive test for patients with and female carriers of DMD/BMD: a multi-population diagnostic study. Eur J Hum Genet (2013) 0.94

Linkage analysis of X linked retinitis pigmentosa in the Irish population. J Med Genet (1988) 0.94

The screening of Duchenne muscular dystrophy patients for submicroscopic deletions. J Med Genet (1986) 0.93

Linkage analysis of polymorphisms within the DNA fragment XJ cloned from the breakpoint of an X;21 translocation associated with X linked muscular dystrophy. J Med Genet (1986) 0.92

The natural history of cardiac and pulmonary function decline in patients with duchenne muscular dystrophy. Spine (Phila Pa 1976) (2011) 0.91

Rapid carrier and prenatal diagnosis of Duchenne and Becker muscular dystrophy. Nucleic Acids Res (1989) 0.91

Color vision defects in adrenomyeloneuropathy. Am J Hum Genet (1989) 0.90

Upper extremity 3-dimensional reachable workspace analysis in dystrophinopathy using Kinect. Muscle Nerve (2015) 0.90

Becker muscular dystrophy patient with a large intragenic dystrophin deletion: implications for functional minigenes and gene therapy. J Med Genet (1991) 0.90

Parental somatic and germ-line mosaicism for a multiexon deletion with unusual endpoints in a type III collagen (COL3A1) allele produces Ehlers-Danlos syndrome type IV in the heterozygous offspring. Am J Hum Genet (1993) 0.89

Population data on benign and severe forms of X-linked muscular dystrophy. Hum Genet (1987) 0.88

Introduction to DNA-Based Genetic Diagnostics. Can Fam Physician (1988) 0.87

Prenatal diagnosis of Duchenne muscular dystrophy: prospective linkage analysis and retrospective dystrophin cDNA analysis. Am J Hum Genet (1989) 0.87

Development and validation of laboratory procedures for preimplantation diagnosis of Duchenne muscular dystrophy. J Med Genet (1993) 0.87

Service experience using DNA analysis for genetic prediction in Duchenne muscular dystrophy. J Med Genet (1988) 0.87

Cosegregation of schizophrenia with Becker muscular dystrophy: susceptibility locus for schizophrenia at Xp21 or an effect of the dystrophin gene in the brain? J Med Genet (1993) 0.86

Familial dilated cardiomyopathy. Br Heart J (1994) 0.86

Efficient Restoration of the Dystrophin Gene Reading Frame and Protein Structure in DMD Myoblasts Using the CinDel Method. Mol Ther Nucleic Acids (2016) 0.86

Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy. Physiol Rev (2016) 0.85

Linkage studies in Duchenne and Becker muscular dystrophies. J Med Genet (1986) 0.85

Linkage studies in a new X-linked myopathy, suggesting exclusion of DMD locus and tentative assignment to distal Xq. Am J Hum Genet (1988) 0.85

Reliability and validity of the Chinese version of the Pediatric Quality Of Life InventoryTM (PedsQLTM) 3.0 neuromuscular module in children with Duchenne muscular dystrophy. Health Qual Life Outcomes (2013) 0.84

Prenatal diagnosis of Duchenne muscular dystrophy: a three-year experience in a rapidly evolving field. J Inherit Metab Dis (1989) 0.84

Animal models of muscular dystrophy. Prog Mol Biol Transl Sci (2012) 0.83

Carrier detection and prenatal diagnosis in X linked muscular dystrophy using restriction fragment length polymorphisms. J Med Genet (1986) 0.83

Array-based Identification of Copy Number Changes in a Diagnostic Setting: Simultaneous gene-focused and low resolution whole human genome analysis. Sultan Qaboos Univ Med J (2013) 0.82

The Hox-2 homeo box gene complex on mouse chromosome 11 is closely linked to Re. Genetics (1988) 0.81

Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors. Curr Gene Ther (2012) 0.81

Dystrophin Orchestrates the Epigenetic Profile of Muscle Cells Via miRNAs. Front Genet (2011) 0.79

Chromosomal rearrangement segregating with adrenoleukodystrophy: a molecular analysis. Proc Natl Acad Sci U S A (1993) 0.79

Deletion pattern in the dystrophin gene in Duchenne muscular dystrophy patients in northeast India. J Neurosci Rural Pract (2013) 0.79

Disease course in mdx:utrophin+/- mice: comparison of three mouse models of Duchenne muscular dystrophy. Physiol Rep (2015) 0.78

Cardiovascular Complications of Neuromuscular Disorders. Curr Treat Options Cardiovasc Med (2002) 0.78

Spatio-Temporal Differences in Dystrophin Dynamics at mRNA and Protein Levels Revealed by a Novel FlipTrap Line. PLoS One (2015) 0.78

Localization of dystrophin COOH-terminal domain by the fracture-label technique. J Cell Biol (1992) 0.75

Symptomatic therapy of Duchenne muscular dystrophy (DMD). Acta Myol (2012) 0.75

Corticosteroid Treatment Impact on Spinal Deformity in Duchenne Muscular Dystrophy. Int Sch Res Notices (2014) 0.75

Analysis of RFLPs and DNA deletions in the Chinese Duchenne muscular dystrophy gene. J Med Genet (1991) 0.75

Gene Dosage Analysis in a Clinical Environment: Gene-Targeted Microarrays as the Platform-of-Choice. Microarrays (Basel) (2013) 0.75

How the magnitude of clinical severity and recurrence risk affects reproductive decisions in adult males with different forms of progressive muscular dystrophy. J Med Genet (1998) 0.75

Articles by these authors

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science (1993) 33.32

Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet (1999) 22.84

Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell (1987) 20.27

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA (1997) 17.88

Clinical assessment of gestational age in the newborn infant. J Pediatr (1970) 16.08

Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell (1987) 16.01

Linkage disequilibrium mapping in isolated founder populations: diastrophic dysplasia in Finland. Nat Genet (1992) 15.62

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A (1993) 15.04

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology (1993) 14.54

Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci U S A (1977) 13.87

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature (1995) 13.80

Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science (2009) 13.45

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia (2003) 13.41

Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Health Care (2005) 12.73

LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99

Linkage relationship of a cloned DNA sequence on the short arm of the X chromosome to Duchenne muscular dystrophy. Nature (1982) 11.57

The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell (1988) 10.75

A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature (1998) 10.35

Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res (1988) 9.94

Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature (1991) 9.89

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46

A forkhead-domain gene is mutated in a severe speech and language disorder. Nature (2001) 9.25

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science (1985) 9.12

Linkage analysis of two cloned DNA sequences flanking the Duchenne muscular dystrophy locus on the short arm of the human X chromosome. Nucleic Acids Res (1983) 8.92

DNA diagnostics--molecular techniques and automation. Science (1988) 8.85

Alu polymerase chain reaction: a method for rapid isolation of human-specific sequences from complex DNA sources. Proc Natl Acad Sci U S A (1989) 8.68

Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med (1998) 8.47

Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature (1986) 7.90

HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature (1987) 7.88

A strategy to reveal high-frequency RFLPs along the human X chromosome. Am J Hum Genet (1984) 7.73

Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature (1999) 7.73

The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA (2000) 7.65

Multicolor spectral karyotyping of human chromosomes. Science (1996) 7.65

The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature (1993) 7.39

A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature (1985) 7.34

Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J (1987) 7.32

Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature (1995) 7.11

Absence of expression of the FMR-1 gene in fragile X syndrome. Cell (1991) 7.04

Transcription of the dystrophin gene in human muscle and non-muscle tissue. Nature (1988) 7.00

Human gene mutation database-a biomedical information and research resource. Hum Mutat (2000) 6.87

Methylmercury poisoning in Iraq. Science (1973) 6.84

Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet (2009) 6.83

Matching using estimated propensity scores: relating theory to practice. Biometrics (1996) 6.73

Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer (1999) 6.73

Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med (2000) 6.72

Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution. J Cyclic Nucleotide Res (1975) 6.71

Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell (1993) 6.61

Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med (1985) 6.54

An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics (1988) 6.51

Structure, expression, and mutation of the hypoxanthine phosphoribosyltransferase gene. Proc Natl Acad Sci U S A (1984) 6.48

Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature (1986) 6.45

Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics (1992) 6.40

Cloning the gene for an inherited human disorder--chronic granulomatous disease--on the basis of its chromosomal location. Nature (1986) 6.34

DNA typing and genetic mapping with trimeric and tetrameric tandem repeats. Am J Hum Genet (1991) 6.20

Cloning of a representative genomic library of the human X chromosome after sorting by flow cytometry. Nature (1981) 6.18

Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways. Science (1986) 6.10

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell (1996) 5.99

Automated DNA sequencing of the human HPRT locus. Genomics (1990) 5.92

Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med (1988) 5.84

Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet (2000) 5.77

Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features. J Med Genet (2004) 5.76

Generation of cDNA probes directed by amino acid sequence: cloning of urate oxidase. Science (1988) 5.72

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A (1993) 5.68

Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell (1996) 5.67

Studies on heterologous anti-lymphocyte serum in mice. I. In vitro and in vivo properties. J Immunol (1966) 5.59

Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. Proc Natl Acad Sci U S A (1985) 5.50

Human genes involved in cholesterol metabolism: chromosomal mapping of the loci for the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl-coenzyme A reductase with cDNA probes. Proc Natl Acad Sci U S A (1985) 5.33

An interspersed repeated sequence specific for human subtelomeric regions. EMBO J (1990) 5.30

Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. Science (1985) 5.23

The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping. Cell (1994) 5.21

Disseminated Mycobacterium avium-intracellulare infection in homosexual men dying of acquired immunodeficiency. JAMA (1982) 5.19

Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet (1990) 5.16

Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet (1996) 5.15

The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet (1989) 5.09

Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet (1999) 5.04

Construction of plasmids that express E. coli beta-galactosidase in mammalian cells. Nucleic Acids Res (1989) 5.02

Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet (1990) 4.99

Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A (1998) 4.99

p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol (1999) 4.98

Identification of the gene responsible for Best macular dystrophy. Nat Genet (1998) 4.89

Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy. Nat Genet (1997) 4.87

Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med (1996) 4.87